Puppala Sobha, Dodd Gerald D, Fowler Sharon, Arya Rector, Schneider Jennifer, Farook Vidya S, Granato Richard, Dyer Thomas D, Almasy Laura, Jenkinson Christopher P, Diehl Andrew K, Stern Michael P, Blangero John, Duggirala Ravindranath
Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA.
Am J Hum Genet. 2006 Mar;78(3):377-92. doi: 10.1086/500274. Epub 2006 Jan 6.
Gallbladder disease (GBD) is one of the major digestive diseases. Its risk factors include age, sex, obesity, type 2 diabetes, and metabolic syndrome (MS). The prevalence of GBD is high in minority populations, such as Native and Mexican Americans. Ethnic differences, familial aggregation of GBD, and the identification of susceptibility loci for gallstone disease by use of animal models suggest genetic influences on GBD. However, the major susceptibility loci for GBD in human populations have not been identified. Using ultrasound-based information on GBD occurrence and a 10-cM gene map, we performed multipoint variance-components analysis to localize susceptibility loci for GBD. Phenotypic and genotypic data from 715 individuals in 39 low-income Mexican American families participating in the San Antonio Family Diabetes/Gallbladder Study were used. Two GBD phenotypes were defined for the analyses: (1) clinical or symptomatic GBD, the cases of cholecystectomies due to stones confirmed by ultrasound, and (2) total GBD, the clinical GBD cases plus the stone carriers newly diagnosed by ultrasound. With use of the National Cholesterol Education Program/Adult Treatment Panel III criteria, five MS risk factors were defined: increased waist circumference, hypertriglyceredemia, low high-density lipoprotein cholesterol, hypertension, and high fasting glucose. The MS risk-factor score (range 0-5) for a given individual was used as a single, composite covariate in the genetic analyses. After accounting for the effects of age, sex, and MS risk-factor score, we found stronger linkage signals for the symptomatic GBD phenotype. The highest LOD scores (3.7 and 3.5) occurred on chromosome 1p between markers D1S1597 and D1S407 (1p36.21) and near marker D1S255 (1p34.3), respectively. Other genetic locations (chromosomes 2p, 3q, 4p, 8p, 9p, 10p, and 16q) across the genome exhibited some evidence of linkage (LOD >or=1.2) to symptomatic GBD. Some of these chromosomal regions corresponded with the genetic locations of Lith loci, which influence gallstone formation in mouse models. In conclusion, we found significant evidence of major genetic determinants of symptomatic GBD on chromosome 1p in Mexican Americans.
胆囊疾病(GBD)是主要的消化系统疾病之一。其风险因素包括年龄、性别、肥胖、2型糖尿病和代谢综合征(MS)。在少数族裔人群中,如美国原住民和墨西哥裔美国人,GBD的患病率很高。种族差异、GBD的家族聚集性以及利用动物模型鉴定胆结石疾病的易感基因座表明基因对GBD有影响。然而,人类群体中GBD的主要易感基因座尚未确定。利用基于超声的GBD发生信息和一个10厘摩的基因图谱,我们进行了多点方差成分分析以定位GBD的易感基因座。使用了参与圣安东尼奥家族糖尿病/胆囊研究的39个低收入墨西哥裔美国家庭中715名个体的表型和基因型数据。分析定义了两种GBD表型:(1)临床或有症状的GBD,即因超声证实的结石而进行胆囊切除术的病例;(2)总GBD,即临床GBD病例加上超声新诊断的结石携带者。根据美国国家胆固醇教育计划/成人治疗小组第三次报告的标准,定义了五个MS风险因素:腰围增加、高甘油三酯血症、低高密度脂蛋白胆固醇、高血压和高空腹血糖。给定个体的MS风险因素评分(范围0 - 5)在基因分析中用作单一的综合协变量。在考虑了年龄、性别和MS风险因素评分的影响后,我们发现有症状GBD表型有更强基因连锁信号。最高的对数优势(LOD)分数(3.7和3.5)分别出现在1号染色体p臂上标记D1S1597和D1S407之间(1p36.21)以及标记D1S255附近(1p34.3)。全基因组其他基因位置(2号染色体p臂、3号染色体q臂、4号染色体p臂、8号染色体p臂、9号染色体p臂、10号染色体p臂和16号染色体q臂)显示出与有症状GBD存在一些基因连锁证据(LOD≥1.2)。这些染色体区域中的一些与Lith基因座的基因位置相对应,Lith基因座在小鼠模型中影响胆结石形成。总之,我们发现墨西哥裔美国人中1号染色体p臂上有症状GBD存在主要遗传决定因素的显著证据。